News
Ensuring stronger rules and transparency on medical devices 27-02-2019
Public health stakeholders call for timely application of new medical devices rules
The European Association of Hospital Pharmacists (EAHP), the European Hospital and Healthcare Federation (HOPE), the European Social Insurance Platform (ESIP), the International Association of Mutual Benefit Societies (AIM), Prescrire and the Standing Committee of European Doctors (CPME) call for timely application of the new rules on medical devices and complete transparency concerning high-risk medical devices with public access to Eudamed.
Towards a European tracking system? 18-02-2019
Joint pension communication conference with EAPSPI and Findyourpension
On the 5th of February, the first common (pension) communication conference organized by the associations EAPSPI and ESIP and the FindyourPension initiative took place at the University of Leuven. Representatives from various pension institutions and other stakeholders as well as researchers got together in order to discuss pension communication from a cross-border and cross-pillar perspective.
Platform economy & social insurance - 4 challenges 07-02-2019
Publication of an ESIP study on the coverage of platform workers
The impact of digitalization, especially of the platform economy, is a burning topic in Europe. The number of publications on the size of platform economy and its impact on labour markets is growing. According to the most quoted figure in the EU, the share of people working in the platform economy ranges between 1 and 5 per cent. The views are somewhat polarized, as some see the phenomenon as rupturing the labour market while others find that its impact is minor (at least for now). Less attention has been given to its interplay with social insurance. That is why ESIP decided to take a closer look at that part of the phenomenon.
Timely application of the new medical devices rules 23-01-2019
ESIP's reaction to the "Implant files"
A recent international investigation on medical implants has shed light again on the weaknesses of the system of certification of medical devices. Since 2012, ESIP has been advocating forstrengthening the rules concerning the marketing of medical devices asking in particular for an independent centralised authorisation system for the marketing of high-risk medical devices, better market transparency and improved protection for patients.
